Fecal ESBL Escherichia coli carriage as a risk factor for bacteremia in patients with hematological malignancies

详细信息    查看全文

• 作者：Patricia Cornejo-Ju谩rez ; Juan Antonio Su谩rez-Cuenca…
• 关键词：Colonization ; Escherichia coli ; Extended ; spectrum 尾 ; lactamase ; Mortality ; Bloodstream infection
• 刊名：Supportive Care in Cancer
• 出版年：2016
• 出版时间：January 2016
• 年：2016
• 卷：24
• 期：1
• 页码：253-259
• 全文大小：167 KB
• 参考文献：1.Arnan M, Gudiol C, Calatayud L, Li帽ares J, Dominguez MA, Batlle M et al (2011) Risk factors for, and clinical relevance of, faecal extended-spectrum 尾-lactamase producing Escherichia coli (ESBL-EC) carriage in neutropenic patients with haematological malignancies. Eur J Clin Microbiol Dis 30:355鈥?60. doi:10.鈥?007/鈥媠10096-010-1093-x CrossRef
  2.Yu WL, Chuang YC, Walther-Rasmussen J (2006) Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control. J Microbiol Immunol Infect 39:264鈥?77PubMed
  3.Ben-Ami R, Rodr铆guez-Ba帽o J, Arslan H, Pitout JD, Quentin C, Calbo ES et al (2009) A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 49:682鈥?90. doi:10.鈥?086/鈥?04713 CrossRef PubMed
  4.Melzer M, Petersen I (2007) Mortality following bacteraemic infection caused by extended spectrum beta-lactamase (ESBL) producing Escherichia coli compared to non-ESBL producing E. coli. J Infection 55:254鈥?59CrossRef
  5.Clinical and Laboratory Standards Institute (2011) Performance standards for antimicrobial susceptibility testing. 21st Informational Supplement, M-100-S21. Wayne, PA, USA: CLSI
  6.Kaufmann ME (1988) Pulse-field gel electrophoresis. Methods Mol Med 15:17鈥?1
  7.Akpaka PE, Legall B, Padman J (2010) Molecular detection and epidemiology of extended-spectrum beta-lactamase genes prevalent in clinical isolates of Klebsiella pneumoniae and E. coli from Trinidad and Tobago. West Indian Med J 59:591鈥?96PubMed
  8.Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33:2233鈥?239PubMedCentral PubMed
  9.Clermont O, Bonacorsi S, Bingen E (2000) Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66:4555鈥?558PubMedCentral CrossRef PubMed
  10.Kieser T (1984) Factors affecting the isolation of CCC DNA from Streptomyces lividans and Escherichia coli. Plasmid 12:19鈥?6CrossRef PubMed
  11.Espinal P, Garza-Ramos U, Reyna F, Rojas-Moreno T, Sanchez-Perez A, Carrillo B et al (2010) Identification of SHV-type and CTX-M-12 extended-spectrum beta-lactamases (ESBLs) in multiresistant Enterobacteriaceae from Colombian Caribbean hospitals. Chemotherapy 22:160鈥?64CrossRef
  12.Prodinger WM, Fille M, Bauernfeind A, Stemplinger I, Amann S, Pfausler B et al (1996) Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 beta-lactamase: parallel outbreaks due to multiple plasmid transfer. J Clin Microbiol 34:564鈥?68PubMedCentral PubMed
  13.Ber莽ot B, Poierel L, Silva-S谩nchez J, Nordmann P (2010) Association of the extended-spectrum beta-lactamase gene blaTLA-1 with a novel ISCR element, ISCR20. Antimicrob Agents Chemother 54:4026鈥?028. doi:10.鈥?128/鈥婣AC.鈥?0075-10 PubMedCentral CrossRef PubMed
  14.Chen CY, Tsay W, Tang JL, Tien HF, Chen YC, Chang SC, Hsueh PR (2009) Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Epidemiol Infect 27:1鈥?. doi:10.鈥?017/鈥婼095026880999120鈥?
  15.Levin BR (2001) Minimizing potential resistance: a population dynamics view. Clin Infect Dis 33:S161鈥揝169CrossRef PubMed
  16.Smith DL, Dushoff J, Perencevich EN, Harris AD, Levin SA (2004) Persistent colonization and the spread of antibiotic resistance in nosocomial pathogens: resistance is a regional problem. Proc Natl Acad Sci U S A 101:3709鈥?714PubMedCentral CrossRef PubMed
  17.Tancrede CH, Andremont AO (1985) Bacterial translocation and Gram-negative bacteremia in patients with hematological malignancies. J Infect Dis 152:99鈥?03CrossRef PubMed
  18.Yu WL, Chuang YCH, Rasmussen JW (2006) Extended-spectrum beta-lactamases in Taiwan: epidemiology, detection, treatment and infection control. J Microbiol Immunol Infect 39:264鈥?77PubMed
  19.Ellis M (2008) Febrile neutropenia. Evolving strategies. Ann N Y Acad Sci 1138:329鈥?50CrossRef PubMed
  20.Ilan Y (2012) Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis. World J Gastroenterol 18:2609鈥?618. doi:10.鈥?748/鈥媤jg.鈥媣18.鈥媔21.鈥?609 PubMedCentral CrossRef PubMed
  21.Van Leeuwen PAM, Boermeester MA, Houdijk APJ, Ferwerda CC, Cuesta MA, Meyer S, Wesdorp RIC (1994) Clinical significance of translocation. Gut Suppl 1:S28鈥揝34CrossRef
  22.Hu B, Ye H, Xu Y, Ni Y, Hu Y, Yu Y et al (2010) Clinical and economic outcomes associated with community-acquired intra-abdominal infections caused by extended spectrum beta-lactamase (ESBL) producing bacteria in China. Curr Med Res Opin 26:1443鈥?449. doi:10.鈥?185/鈥?300799100376906鈥? CrossRef PubMed
  23.Cornejo-Ju谩rez P, P茅rez-Jim茅nez C, Silva-S谩nchez J, Vel谩zquez-Acosta C, Gonz谩lez-Lara F, Reyna-Flores F et al (2012) Molecular analysis and risk factors for Escherichia coli producing extended-spectrum 尾-lactamase bloodstream infection in hematological malignancies. PLoS One 7(4):e35780PubMedCentral CrossRef PubMed
  24.Hayakawa K, Gattu S, Marchaim D, Bhargava A, Palla M, Alshabani K et al (2013) Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum 尾-lactamase in a large U.S. medical center. Antimicrob Agents 57:4010鈥?018. doi:10.鈥?128/鈥婣AC.鈥?2516-12 CrossRef
  25.Liss BJ, Vehreschild JJ, Cornely OA, Hallek M, F盲tkenheuer G, Wisplinghoff H et al (2012) Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL) in patients with haematological and oncological malignancies. Infection 40:613鈥?19. doi:10.鈥?007/鈥媠15010-012-0269-y CrossRef PubMed
  26.Schwaber MJ, Carmeli Y (2008) Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA 300:2911鈥?913. doi:10.鈥?001/鈥媕ama.鈥?008.鈥?96 CrossRef PubMed
  27.Kang CL, Chung DR, Ko KS, Peck KR, Song JH, Korean Network for study of infectious diseases (2012) Risk factors for infection and treatment outcome of extended-spectrum 尾-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in patients with hematologic malignancy. Ann Hematol 91:115鈥?21. doi:10.鈥?007/鈥媠00277-011-1247-7 CrossRef PubMed
  28.Falagas ME, Karaeorgopoulos DE (2009) Extended-spectrum 尾-lactamase-producing organisms. J Hosp Infect 73:345鈥?54CrossRef PubMed
  29.Wu UI, Wang JL, Chen WC, Chang SC, Chen YC (2011) Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases. Eur J Clin Microbiol Infect Dis 30:33鈥?9CrossRef PubMed
  30.Clermont O, Lavollay M, Vimont S, Deschamps C, Forestier C, Branger C et al (2008) The CTX-M-15 producing Escherichia coli diffusing clone belongs to a highly virulent B2 phylogenetic subgroup. J Antimicrob Chemother 61:1024鈥?028. doi:10.鈥?093/鈥媕ac/鈥媎kn084 CrossRef PubMed
  31.Reyna-Flores F, Barrios H, Garza-Ramos U, S谩nchez-P茅rez A, Rojas-Moreno T, Uribe-Salas FJ et al (2013) Molecular epidemiology of Escherichia coli O25b-ST131 isolates causing community-acquired UTIs in Mexico. Diagn Microbiol Infect Dis 76:396鈥?98. doi:10.鈥?016/鈥媕.鈥媎iagmicrobio.鈥?013.鈥?3.鈥?26 CrossRef PubMed
  32.Morf铆n-Otero R, Mendoza-Olazar谩n S, Silva-S谩nchez J, Rodr铆guez-Noriega E, Laca-D铆az J, Tinoco-Carrillo P et al (2013) Characterization of Enterobacteriaceae isolates obtained from a tertiary care hospital in Mexico, which produces extended-spectrum 尾-lactamase. Microb Drug Resist 19:378鈥?83. doi:10.鈥?089/鈥媘dr.鈥?012.鈥?263 CrossRef PubMed
  33.Paterson DL, Bonomo RA (2005) Extended-spectrum 尾-lactamases: a clinical update. Clin Microbiol Rev 18:657鈥?86PubMedCentral CrossRef PubMed
  34.Clermont O, Dhanji H, Upton M, Gribeel T, Fox A, Boyd D et al (2009) Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J Antimicrob Chemother 64:274鈥?77. doi:10.鈥?093/鈥媕ac/鈥媎kp194 CrossRef PubMed
  
• 作者单位：Patricia Cornejo-Ju谩rez (1)
  Juan Antonio Su谩rez-Cuenca (2)
  Patricia Volkow-Fern谩ndez (1)
  Jes煤s Silva-S谩nchez (3)
  Humberto Barrios-Camacho (3)
  Esmeralda N谩jera-Le贸n (4)
  Consuelo Vel谩zquez-Acosta (1)
  Diana Vilar-Compte (1)
  
  1. Department of Infectious Diseases, Instituto Nacional de Cancerolog铆a (INCan), Av. San Fernando No. 22, Col. Secci贸n XVI, Tlalpan, 14000, Mexico City, DF, Mexico
  2. Division of Clinical Research, 鈥?0 de Noviembre,鈥?National Medical Center, ISSSTE, Mexico City, Mexico
  3. Departamento de Diagn贸stico Epidemiol贸gico, Centro de Investigaci贸n sobre Enfermedades Infecciosas, Instituto Nacional de Salud P煤blica (INSP), Cuernavaca, Morelos, Mexico
  4. INSP, Cuernavaca, Morelos, Mexico
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Oncology
  Nursing
  Nursing Management and Research
  Pain Medicine
  Rehabilitation Medicine
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1433-7339

文摘

Purpose The purpose of this study is to evaluate the impact of fecal extended-spectrum 尾-lactamase-producing Escherichia coli (ESBL-EC) colonization for bloodstream infection (BSI), clinical outcome, and costs in patients with hematologic malignancies (HM) and severe neutropenia.